Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
761 to 780 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01HL141917 | Improving Mitral Compensation In Ischemic Regurgitation | 2 | 2021 |
| R33AR076803 | Uncover the new subsets of epidermal Langerhans cells | 2 | 2021 |
| R35GM122542 | Mechanisms regulating apoptotic cell clearance in health and disease | 2 | 2021 |
| R50CA221675 | Functional Proteomics by Reverse Phase Protein Array in Cancer | 2 | 2021 |
| T32GM007491 | Training Program in Cellular and Molecular Biology and Genetics | 2 | 2021 |
| U01CA215709 | Precision lung cancer therapy design through multiplexed adapter measurement | 2 | 2021 |
| U41HG003751 | Reactome: An Open Knowledgebase of Human Pathways | 2 | 2021 |
| U54CA209891 | Research Center for Cancer Systems Biology: Cancer Cell Map Initiative | 2 | 2021 |
| U54CA217377 | Quantitative and functional characterization of therapeutic resistance in cancer | 2 | 2021 |
| F30CA247601 | Defining extracellular vesicle-mediated drug resistance in AML | 1 | 2021 |
| F31CA228373 | Targeting glycolytic metabolism in RON-driven breast cancer | 1 | 2021 |
| F31CA239445 | Gas6 regulation of premalignant mammary cells | 1 | 2021 |
| F31CA247248 | Targeting cancer-stroma interactions in breast cancer metastasis using organotypic modeling | 1 | 2021 |
| F31HL154725 | Computational modeling of stem cells predicts clinical trial outcomes for hypoplastic left heart syndrome | 1 | 2021 |
| F32CA247414 | A Pharmacogenomic Approach Using Precision Models of Hepatocellular Carcinoma to Identify Novel Therapeutics | 1 | 2021 |
| I01BX003705 | Cardiolipin as a Novel Target for Neuroprotection after Spinal Cord Injury | 1 | 2021 |
| K08CA215105 | Precision Medicine by Targeting Cell Adhesion in Melanoma | 1 | 2021 |
| K08CA222663 | Dissecting mechanisms of immunotherapy resistance in melanoma patients | 1 | 2021 |
| K08DK114527 | Role of the Lin28b/let-7 axis in the maturation of hematopoietic progenitor cells | 1 | 2021 |
| K08HL140143 | Functional and transcriptional analysis of embryonic hematopoietic stem cell development at the single cell level | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=39